[1]牛波,池跃朋,帅金凤,等. 儿童难治性肺炎支原体肺炎免疫机制探讨[J]. 中国医药导报, 2016, 13(6): 107-110.
[2]Chkhaidze I, Kapanadze N. Cytokines as the predictors of severe mycoplasma pneumoniae pneumonia in children [J]. Georgian Med News, 2017, 6(267): 89-95.
[3]黄静,代永红. 难治性新生儿肺炎危险因素分析[J]. 现代仪器与医疗, 2016, 22(3): 65-66.
[4]赵志伟,宋曼莉. 儿童肺炎支原体感染三种实验诊断方法评价[J]. 中国医学创新, 2017, 14(25): 64-67.
[5]李华浚,陈啸洪,章杭湖,等. 阿奇霉素联合甲泼尼龙治疗肺炎支原体肺炎患儿的临床研究[J]. 中国临床药理学杂志, 2015, 9(10): 771-773.
[6]Yang HJ, Song DJ, Shim JY. Mechanism of resistance acquisition and treatment of macrolide-resistant mycoplasma pneumoniae pneumonia in children [J]. Korean J Pediatr, 2017, 60(6): 167-174.
[7]中华医学会儿科学分会呼吸学组. 儿童社区获得性肺炎管理指南(2013修订)(下)[J]. 中华儿科杂志, 2013, 51(11): 856-862.
[8]《抗菌药物临床应用指导原则》修订工作组. 抗菌药物临床应用指导原则: 2015年版[M].北京:人民卫生出版社, 2015:1-184.
[9]Guo H, He Z, Li M, et al. Imbalance of peripheral blood Th17 and Treg responses in children with refractory mycoplasma pneumoniae pneumonia [J]. J Infect Chemother, 2016, 22(3): 162-166.
[10]钟晓,田宝琳,焦安夏,等. 儿童难治性肺炎支原体肺炎44例临床分析[J]. 中国实用儿科杂志, 2015, 10(8): 622-624.
[11]Huang L, Chen H, Peng S. Spontaneous pneumomediastinum, emphysema, and pulmonary bullae associated with refractory mycoplasma pneumoniae pneumonia in a child [J]. Pediatr Pulmonol, 2017, 52(10): 77-80.
[12]孜维地古丽·买买提,拜尓娜·那扎瓦尓,艾力克木·阿不都玩克,等. 难治性肺炎支原体肺炎患儿支气管肺泡灌洗液和血清 IFN-γ、IL-4、IL-6水平及其临床意义[J]. 疑难病杂志, 2015, 10(9): 950-952.
[13]王臻,李雅春,陈璐. 儿童难治性肺炎支原体肺炎的早期识别[J]. 中国当代儿科杂志, 2015, 17(11): 1189-1192.
[14]Bao YX, Li J, Tian Y, et al. Atopy: a risk factor of refractory mycoplasma pneumoniae pneumonia [J]? Clin Respir J, 2017, 11(6): 931-934.
[15]田红艳. 儿童肺炎支原体感染检测结果分析[J]. 保健医学研究与实践, 2016, 13(5): 70-71.
[16]陈丽兰. 常量甲泼尼龙治疗无效的儿童难治性肺炎支原体肺炎的临床特征和治疗方案探讨[J]. 河北医学, 2016, 22(1): 147-150.
[17]陈璐,孟燕妮,黄建宝,等. 纤维支气管镜在儿童难治性肺炎支原体肺炎合并肺不张诊治中的应用[J].实用临床医药杂志, 2015, 19(23): 78-81.
[18]Zhang Y, Chen Y, Chen Z, et al. Effects of bronchoalveolar lavage on refractory mycoplasma pneumoniae pneumonia [J]. Respir Care, 2014, 59(9): 1433-1439.
[19]戴洪法,廖翠乐,米沛明. 纤维支气管镜下支气管肺泡灌洗在儿童重症肺炎支原体肺炎中的应用价值[J].中国医学创新, 2018, 4(12): 48-51.
[20]吴小磊,张慧玉,田玲,等. 电子支气管镜诊治儿童难治性肺炎支原体肺炎临床研究[J]. 中国实用儿科杂志, 2015(3): 190-193.
[21]甄波,胡国斌,曾艳. 难治性肺炎支原体肺炎患儿血清炎性细胞因子水平变化及意义[J]. 山东医药, 2015, 10(44): 73-75.
[22]Xu Q, Zhang L, Hao C, et al. Prediction of bronchial mucus plugs formation in patients with refractory mycoplasma pneumoniae pneumonia [J]. J Trop Pediatr, 2017, 63(2): 148-154.
[23]贺晓露,李渠北. 儿童难治性肺炎支原体肺炎抗菌药物治疗进展[J]. 儿科药学杂志, 2016, 6(4): 54-57.
[24]Shan LS, Liu X, Kang XY, et al. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory mycoplasma pneumoniae pneumonia in children[J]. World J Pediatr, 2017, 13(4): 321-327.
[25]张新星,陈正荣,顾文婧,等. 难治性肺炎支原体肺炎患儿肺泡灌洗液中sB7-H3及细胞因子表达[J].临床儿科杂志, 2016, 34(8): 561-565. |